When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
DCPH - Deciphera Pharmaceuticals EPS beats by $0.07 beats on revenue
Deciphera Pharmaceuticals Inc.
Deciphera Pharmaceuticals (DCPH): Q4 GAAP EPS of -$1.10 beats by $0.07.Revenue of $19.49M beats by $1.07M.Cash, equivalents and marketable securities were $561.3M.Top-line results in INTRIGUE Phase 3 Study of QINLOCK in patients with second-line GIST expected in 2H 2021.Pipeline candidates, Vimseltinib (DCC-3014), Rebastinib and DCC-3116, continue to advance with significant clinical milestones expected in 2021.Press Release